Skip to content

Clinical trials

Phase 1/2 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Norway Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20056
20065
20076
20081
20093
20102
20114
20124
20137
20146
20158
20166
20179
20189
20194
20208
20218
20223
20236
20243
202512
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Recruiting27
Terminated12
Unknown status10
Active, not recruiting8
Withdrawn2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital20
Merck Sharp & Dohme LLC8
Bristol-Myers Squibb6
GlaxoSmithKline6
Haukeland University Hospital6
Norwegian University of Science and Technology6
St. Olavs Hospital4
University of Oslo4
Novartis Pharmaceuticals3
Princess Maxima Center for Pediatric Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma11
Colorectal Neoplasms8
Neoplasms7
Recurrence7
Carcinoma, Non-Small-Cell Lung6
Esophageal Neoplasms6
Leukemia, Myeloid, Acute6
Melanoma6
Prostatic Neoplasms5
Esophageal Squamous Cell Carcinoma4

Trials

Showing 51 to 75 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.